Cargando…

Essential thrombocythemia, hemolytic anemia and hepatic cirrhosis: Could there be an association?

Vascular events are the most common clinical complication of essential thrombocythemia, leading to sign and symptoms of this disease. There are various sign and symptoms of essential thrombocythemia, such as thrombosis in artery or vein, and enlarged spleen. Portal hypertension and hepatic cirrhosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Lugito, Nata Pratama Hardjo, Kurniawan, Andree, Kurniawan, Yohanes Chandra, Yacobus, Enny, Halim, Edwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176381/
https://www.ncbi.nlm.nih.gov/pubmed/30344986
http://dx.doi.org/10.4081/hr.2018.7394
_version_ 1783361691204976640
author Lugito, Nata Pratama Hardjo
Kurniawan, Andree
Kurniawan, Yohanes Chandra
Yacobus, Enny
Halim, Edwin
author_facet Lugito, Nata Pratama Hardjo
Kurniawan, Andree
Kurniawan, Yohanes Chandra
Yacobus, Enny
Halim, Edwin
author_sort Lugito, Nata Pratama Hardjo
collection PubMed
description Vascular events are the most common clinical complication of essential thrombocythemia, leading to sign and symptoms of this disease. There are various sign and symptoms of essential thrombocythemia, such as thrombosis in artery or vein, and enlarged spleen. Portal hypertension and hepatic cirrhosis could be caused by essential thrombocythemia via intrahepatic thrombus. Anemia in essential thrombocythemia patient treated with hydroxyurea could be the side effect of bone marrow supression and also hydroxyurea induced hemolytic anemia. Association betweeen autoimmune hemolytic anemia and primary biliary cirrhosis or hepatic cirrhosis has been discussed. This case report presented an patient diagnosed with essential thrombocythemia. He later developed hepatic cirrhosis possibly caused by intra hepatic thrombus in the setting of hypercoagulabuility in myeloproliverative disorders. He also sufferred from anemia due to hydroxyurea induced hemolytic anemia. Association between autoimmune hepatic cirrhosis and autoimmune hemolytic anemia should also be considered in this patient.
format Online
Article
Text
id pubmed-6176381
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-61763812018-10-19 Essential thrombocythemia, hemolytic anemia and hepatic cirrhosis: Could there be an association? Lugito, Nata Pratama Hardjo Kurniawan, Andree Kurniawan, Yohanes Chandra Yacobus, Enny Halim, Edwin Hematol Rep Brief Report Vascular events are the most common clinical complication of essential thrombocythemia, leading to sign and symptoms of this disease. There are various sign and symptoms of essential thrombocythemia, such as thrombosis in artery or vein, and enlarged spleen. Portal hypertension and hepatic cirrhosis could be caused by essential thrombocythemia via intrahepatic thrombus. Anemia in essential thrombocythemia patient treated with hydroxyurea could be the side effect of bone marrow supression and also hydroxyurea induced hemolytic anemia. Association betweeen autoimmune hemolytic anemia and primary biliary cirrhosis or hepatic cirrhosis has been discussed. This case report presented an patient diagnosed with essential thrombocythemia. He later developed hepatic cirrhosis possibly caused by intra hepatic thrombus in the setting of hypercoagulabuility in myeloproliverative disorders. He also sufferred from anemia due to hydroxyurea induced hemolytic anemia. Association between autoimmune hepatic cirrhosis and autoimmune hemolytic anemia should also be considered in this patient. PAGEPress Publications, Pavia, Italy 2018-09-24 /pmc/articles/PMC6176381/ /pubmed/30344986 http://dx.doi.org/10.4081/hr.2018.7394 Text en ©Copyright N.P.H. Lugito et al., 2018 http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Report
Lugito, Nata Pratama Hardjo
Kurniawan, Andree
Kurniawan, Yohanes Chandra
Yacobus, Enny
Halim, Edwin
Essential thrombocythemia, hemolytic anemia and hepatic cirrhosis: Could there be an association?
title Essential thrombocythemia, hemolytic anemia and hepatic cirrhosis: Could there be an association?
title_full Essential thrombocythemia, hemolytic anemia and hepatic cirrhosis: Could there be an association?
title_fullStr Essential thrombocythemia, hemolytic anemia and hepatic cirrhosis: Could there be an association?
title_full_unstemmed Essential thrombocythemia, hemolytic anemia and hepatic cirrhosis: Could there be an association?
title_short Essential thrombocythemia, hemolytic anemia and hepatic cirrhosis: Could there be an association?
title_sort essential thrombocythemia, hemolytic anemia and hepatic cirrhosis: could there be an association?
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176381/
https://www.ncbi.nlm.nih.gov/pubmed/30344986
http://dx.doi.org/10.4081/hr.2018.7394
work_keys_str_mv AT lugitonatapratamahardjo essentialthrombocythemiahemolyticanemiaandhepaticcirrhosiscouldtherebeanassociation
AT kurniawanandree essentialthrombocythemiahemolyticanemiaandhepaticcirrhosiscouldtherebeanassociation
AT kurniawanyohaneschandra essentialthrombocythemiahemolyticanemiaandhepaticcirrhosiscouldtherebeanassociation
AT yacobusenny essentialthrombocythemiahemolyticanemiaandhepaticcirrhosiscouldtherebeanassociation
AT halimedwin essentialthrombocythemiahemolyticanemiaandhepaticcirrhosiscouldtherebeanassociation